Skip to Content

User Reviews for Rituximab to treat Mantle Cell Lymphoma

Also known as: Rituxan, Truxima, Ruxience

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Reviews for Rituximab

No reviews have yet been submitted. Be the first to review this drug.

Learn more about Mantle Cell Lymphoma

ICD-10 CM Clinical Codes (External)

Look up ICD10 codes for Mantle Cell Lymphoma on icd-codes.com

More about rituximab

Consumer resources

Other brands: Rituxan

Professional resources

Related treatment guides

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Latest: FDA Approves Ruxience (rituximab-pvvr), a Biosimilar to Rituxan

Drug Class

Antirheumatics
CD20 monoclonal antibodies

Related Drugs

prednisone, methotrexate, Humira, Plaquenil, azathioprine, Enbrel, Remicade, Rituxan, Revlimid, cyclophosphamide

Subscribe to our newsletters

Drugs.com Discount Card

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 July 2019), Cerner Multum™ (updated 1 July 2019), Wolters Kluwer™ (updated 29 June 2019) and others.